Company Director at $RH Offloads 2,000 Shares in Insider Sale

Street analysts have recently provided insights into $RH, with 9 firms issuing buy ratings and 2 issuing sell ratings. Among the prominent analyst ratings, Barclays indicated an “Overweight” rating, Stifel recommended a “Buy,” and TD Cowen also advocated a “Buy.” Guggenheim, Wells Fargo, Telsey Advisory Group, and Zelman & Assoc have all expressed positive sentiments towards the stock with “Overweight” and “Outperform” ratings.

In terms of price targets for $RH, multiple analysts have shared their forecasts. Over the last 6 months, 15 analysts have proposed targets for the stock, with a median target of $250. Noteworthy price targets include TD Cowen’s Max Rakhlenko setting a target of $265, and Barclays’ Seth Sigman suggesting $385. Telsey Advisory Group’s Cristina Fernandez aimed for $220, while Guggenheim’s Steven Forbes and Stifel’s W. Andrew Carter set targets at $300 and $320, respectively. Wells Fargo’s Zachary Fadem suggested $295, with Steven Zaccone from Citigroup setting a target price of $233.

It is essential to mention that this article does not provide financial advice. For more details, refer to Quiver Quantitative’s disclaimers.

In summary, the recent insider sale of 2,000 shares by director MARK S DEMILIO at $RH, the trading activities of institutional investors, congressional stock trading, analyst ratings, and price targets for $RH provide valuable insights into the dynamics of the company’s stock. Monitoring these various indicators can offer investors a comprehensive understanding of the market sentiment surrounding $RH and potentially guide investment decision-making processes.